Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glutamate receptor gating.

Kevin Erreger1, Philip E Chen, David J A Wyllie

  • 1Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia 30322-3090, USA. kerrege@emory.edu

Critical Reviews in Neurobiology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptor" [Molecular Pharmacology 108 (2026) 100104].

Molecular pharmacology·2026
Same author

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

medRxiv : the preprint server for health sciences·2026
Same author

Claudin 24-A novel enhancer of AMPA receptor fidelity.

Science advances·2026
Same author

A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptor.

Molecular pharmacology·2026
Same author

Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Molecular psychiatry·2026
Same author

Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequency.

Epilepsia·2026

Ionotropic glutamate receptors (iGluRs) are key for brain excitation. Recent structural studies illuminate how these AMPA, kainate, and NMDA receptor channels open and close upon agonist binding.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Ionotropic glutamate receptors (iGluRs) are crucial for fast excitatory neurotransmission in the mammalian central nervous system (CNS).
  • Advances in protein crystallization have provided detailed structural insights into ion channel proteins.
  • This structural information offers a new lens for interpreting functional data on iGluRs.

Purpose of the Study:

  • To summarize and compare recent functional and structural findings for AMPA, kainate, and NMDA receptor subtypes.
  • To emphasize the relationship between agonist binding and channel gating control in iGluRs.

Main Methods:

  • Review of recent scientific literature on iGluR structure and function.
  • Comparative analysis of structural data from crystallized iGluR complexes.

Related Experiment Videos

  • Integration of structural findings with existing functional data.

    • Main Results:

    • Detailed structural information is available for key iGluR subtypes (AMPA, kainate, NMDA).
    • Structural data provide a framework for understanding how ligand binding translates to channel opening and closing.
    • Specific structural features governing channel gating have been elucidated.

    Conclusions:

    • Recent structural studies have significantly advanced our understanding of iGluR mechanisms.
    • The interplay between structure and function is critical for iGluR activity.
    • This knowledge is vital for interpreting neurological processes and potential therapeutic targets.